Home » News » Boerse Express – New York Stock Outlook: Earnings

Boerse Express – New York Stock Outlook: Earnings

video-tag-article">

NEW YORK (dpa-AFX) – The US stock exchanges were allowed to start the new week with profits after the mixed weekly close. Forty-five minutes before the start of the stock market on Monday, the broker IG appraised the leading index Dow Jones Industrial 0.5 percent higher to 32,954 points. The tech-heavy Nasdaq 100
should increase even more.

After the surprisingly strong US labor market report on Friday, at least the Dow defied the fear of interest rates rising too quickly among the most important indices. On Wednesday, the debate about the future course of the US Federal Reserve to combat high inflation should pick up speed again. Then the consumer price data for July will be released. In June, inflation in the US rose to 9.1 percent, the highest level in over 40 years.

According to statements by members of the US Federal Reserve, a further significant rise in interest rates is to be expected in the USA. The Fed is “far from done with the task of bringing down inflation,” said San Francisco Regional Federal Reserve Chair Mary Daly. According to Fed member Michelle Bowman, the central bank should react to the high inflation in the USA with “a similarly large” interest rate hike at the upcoming meeting. The Fed last raised interest rates by 0.75 percentage points at the end of July in order to curb inflation.

Higher interest rates make equities look worse than other forms of investment, such as bonds, and make borrowing more expensive, which can slow economic growth. For now, however, investors are confident that the Fed can keep inflation in check without plunging the US into a deep recession.

Under the individual values ​​are the papers from Pfizer
in focus. As speculated last week, the pharmaceutical company wants to buy Global Blood Therapeutics (GBT) strengthen its rare hematology business. GBT shares are now up nearly 5 percent in US premarket trading after surging on Thursday and Friday. Pfizer’s stock barely moved.

Avalara shares lost almost five percent before the market. The investment company Vista Equity, which specializes in business software, wants to take over the company, but the offer of USD 93.50 per share apparently did not convince investors. In addition, the sales generated in the second quarter were disappointing.

Investors are downright shocked by Palantir’s outlook . The papers of the data analysis company fell by around 14 percent before the market. At the pharmaceutical company Biontech
business in the second quarter was worse than expected, the shares lost almost eight percent./la/jha

 ISIN  US2605661048  US6311011026  US78378X1072

AXC0178 2022-08-08/15:06

Copyright dpa-AFX business news GmbH. All rights reserved. Redistribution, republication or permanent storage without the express prior consent of dpa-AFX is not permitted.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.